CAS NO: | 514200-66-9 |
生物活性 | COG 133 is a fragment of Apolipoprotein E (APOE) peptide. COG 133 competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 is also anAChRantagonist with anIC50of 445 nM[1][2]. | ||||||||
IC50& Target | IC50: 445 nM (nAChR)[2] | ||||||||
体内研究 (In Vivo) | COG 133 (1 mg/kg; intratracheal administration; every other day; for 4 weeks) treatment impairs the resolution of pulmonary fibrosis in mice[3].
| ||||||||
分子量 | 2169.71 | ||||||||
Formula | C97H181N37O19 | ||||||||
CAS 号 | 514200-66-9 | ||||||||
Sequence | Ac-Leu-Arg-Val-Arg-Leu-Ala-Ser-His-Leu-Arg-Lys-Leu-Arg-Lys-Arg-Leu-Leu-NH2 | ||||||||
Sequence Shortening | Ac-LRVRLASHLRKLRKRLL-NH2 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |